Estimated antiretroviral therapy coverage among children in Chad
Chad: Estimated antiretroviral therapy coverage among children was 29 in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among children in Chad, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for estimated antiretroviral therapy coverage among children in Chad is 29, measured in 2025. That is the highest value across all 26 years on record.
Compared with earlier readings it is up 45.0% on the previous year and up 222.2% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among children in Chad peaked at 29 in 2025 and was at its lowest, 0, in 2000.
That places Chad 71st out of 89 countries with data for 2025, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among children in Chad, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0 | — |
| 2001 | 0 | — |
| 2002 | 0 | — |
| 2003 | 0 | — |
| 2004 | 0 | — |
| 2005 | 0 | — |
| 2006 | 0 | — |
| 2007 | 0 | — |
| 2008 | 2 | — |
| 2009 | 4 | +100.0% |
| 2010 | 5 | +25.0% |
| 2011 | 8 | +60.0% |
| 2012 | 8 | +0.0% |
| 2013 | 8 | +0.0% |
| 2014 | 8 | +0.0% |
| 2015 | 9 | +12.5% |
| 2016 | 9 | +0.0% |
| 2017 | 9 | +0.0% |
| 2018 | 9 | +0.0% |
| 2019 | 10 | +11.1% |
| 2020 | 9 | -10.0% |
| 2021 | 10 | +11.1% |
| 2022 | 11 | +10.0% |
| 2023 | 15 | +36.4% |
| 2024 | 20 | +33.3% |
| 2025 | 29 | +45.0% |
Chad compared with similar countries
- Chad's 29 is below the median for low income countries, which is 41, 71% of the median. (23 countries reporting)
- Chad's 29 is below the median for Sub-Saharan Africa, which is 51, 57% of the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.6 | 0 | 4 | 10 |
| 2010s | 8.3 | 5 | 10 | 10 |
| 2020s | 15.67 | 9 | 29 | 6 |
Countries ranked near Chad
More health data for Chad
- Un projection of annual infant deaths, annual growth rate -0.9964 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6578 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,071 deaths per 1,000 people (2090)
- Number of infants who die before age 1 41,435 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 245 (2025)
- Population ages 00-04, female, annual growth rate 3.76 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0898 units per person (2025)
- Population ages 00-04, male, annual growth rate 3.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among children in Chad?
- Estimated antiretroviral therapy coverage among children in Chad was 29 in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among children recorded in Chad?
- The highest recorded value was 29 in 2025.
- What is the lowest estimated antiretroviral therapy coverage among children recorded in Chad?
- The lowest recorded value was 0 in 2000.
- How does Chad rank for estimated antiretroviral therapy coverage among children?
- Chad ranks 71st out of 89 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among children rising or falling in Chad?
- Over the last ten years it is up 222.2%. The long-run trend across the full record is volatile.
- Where does this Chad data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among children. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).